查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403333

全球太空基因組學和轉錄組學市場：按類型、技術、應用、產品和最終用戶 - 預測（~2031 年）

Spatial Genomics Market by Type (Genomics, Transcriptomics) Technology (Sequencing, Imaging) Application (Oncology, Neurology) Offering (Consumables, Instrument, Software) End User (Pharmaceutical & Biotechnology, CRO) - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 198 Pages | 訂單完成後即時交付

價格

至2031年，全球太空基因組學和轉錄組學市場規模預計將達到32.3億美元，2024年至2031年複合年增長率為27.8%。

該報告在廣泛的二級和一級研究以及對市場情景的深入分析後，對關鍵行業驅動因素、限制因素、挑戰和機會進行了分析。空間基因組學市場的成長是由空間基因組學在藥物發現研究和開發中的使用擴展、空間基因組學在癌症研究中的使用擴展、下一代測序（NGS）的進步、空間基因組學的擴展、空間基因組學在生物標記檢測和癌症研究中的應用。這是由於以下疾病盛行率的增加所驅動的然而，基因組學缺乏標準化方法以及對基因組資料安全和隱私的擔憂正在限制該市場的成長。

此外，個人化藥物和基因療法的日益普及，以及空間基因組學投資的增加，預計將為在該市場運營的公司提供成長機會。然而，數據分析的複雜性和技術實施緩慢是影響市場成長的主要挑戰。

該報告基於對多年來（2020-2024 年）領先產業參與者所採用的產品組合、區域發展和關鍵策略發展的廣泛評估，提供了競爭格局。全球太空基因組學和轉錄組學市場的主要公司包括 NanoString Technologies, Inc.（美國）、10X Genomics, Inc.（美國）、Illumina, Inc.（美國）、Oxford Nanopore Technologies Plc（英國）、Akoya Biosciences、 Inc.（美國）、Revvity, Inc.（美國）、S2 Genomics, Inc.（美國）、Cantata Bio（美國）、Vizgen Inc.（美國）、Biospyder Technologies Inc.（美國）。）、Resolve Biosciences GmbH（德國）

在本報告研究的所有產品中，設備領域預計在預測期內複合年增長率最高。學術和研究機構採用空間轉錄組學進行腫瘤微環境分析、藥物發現和轉化研究，對空間基因組學設備的需求產生了積極影響。此外，主要市場參與者推出的產品正在支持市場成長。例如，2022年12月，10X Genomics, Inc.（美國）推出了用於細胞內原位分析的Xenium分析儀。

在本報告研究的所有類型中，轉錄組學領域預計將在 2024 年佔據空間基因組學和轉錄組學市場的最大份額。此細分市場的最大份額歸因於空間轉錄組學的日益使用，以提供轉化研究所需的整個組織切片內轉錄活性的完整路線圖。此外，用於識別細胞成分的空間轉錄組學技術的日益接受也推動了市場的成長。

在本報告調查的所有技術中，基於序列的細分市場預計在預測期內複合年增長率最高。該領域的成長歸因於NGS平台以顯著降低的成本提供卓越的定序能力，從而增加了NGS在產生大量基因組定序數據的基因組研究中的使用。此外，高通量、低成本、單一細胞表徵和多個目標的分析正在推動市場成長。

在本報告調查的所有應用中，預計到 2024 年，腫瘤學將佔據空間基因組學和轉錄組學市場的最大份額。空間基因組學和轉錄組學在腫瘤生物學中的應用不斷增加，例如研究腫瘤異質性、檢測浸潤免疫細胞的存在以及洞察腫瘤微環境，為這一領域帶來了最大的份額。此外，主要市場參與者推出的產品佔了最大的份額。例如，2023 年 4 月，Akoya Biosciences（美國）推出了 PhenoCode Discovery Panel，以推進癌症研究。

在本報告研究的所有最終用戶中，製藥和生技公司領域預計在預測期內將以最高的複合年增長率成長。這一增長的推動因素包括製藥和生物技術公司研發的增加、研究方法中空間基因組學分析的使用增加以及生物技術公司的增加。此外，慢性病的增加加速了加快藥物開發進程的需求，進一步推動了製藥公司採用空間基因組學。

對全球空間基因組學和轉錄組學市場區域狀況的詳細分析為五個關鍵區域（北美、歐洲、亞太地區、拉丁美洲、中東和非洲）提供了詳細的定性和定量見解，涵蓋了主要國家。到 2024 年，北美預計將佔據空間基因組學和轉錄組學市場的最大份額。北美在該地區佔據主導地位，這主要是因為其擁有大量從事基因組學研究的受人尊敬的研究機構、大學和組織。由於對藥物研發的大量投資以及主要行業參與者的存在，該地區在癌症基因組學的發展中發揮關鍵作用。例如，加拿大製藥公司用於藥物發現的研發支出不斷增加，推動了對空間基因組學的需求。例如，2020 年加拿大製藥業的研發總支出預計在 18 億美元至 24 億美元之間，而 2019 年為 16 億美元至 22 億美元。

目錄

第一章簡介

第二章研究方法

第三章執行摘要

第四章市場洞察

  • 市場
  • 概述
  • 影響市場成長的因素
    • 市場動態影響分析
      • 擴大空間基因組學在藥物發現和市場開發的應用將推動市場成長
      • 缺乏標準化和對基因組數據隱私的擔憂限制了空間基因組學產品的採用
      • 個人化醫療的普及為進入市場的公司創造了成長機會
      • 數據分析的複雜性仍然是影響市場成長的關鍵挑戰
    • 因子分析
  • 技術趨勢
    • 將人工智慧 (AI) 融入空間基因組學
    • 多重空間基因體學
  • 投融資場景
  • 價格分析
  • 波特五力分析

第五章 空間基因組學和轉錄組學市場評估：透過提供

  • 概述
  • 機器
  • 消耗品
  • 軟件服務

第六章 空間基因組學和轉錄組學市場評估：按類型

  • 概述
  • 轉錄組學
  • 基因組學

第七章 空間基因組學和轉錄組學市場評估：按技術

  • 概述
  • 影像基地
  • 基於序列

第八章空間基因組學和轉錄組學市場評估：按應用

  • 概述
  • 腫瘤學
  • 神經病學
  • 其他用途

第 9 章 空間基因組學和轉錄組學市場評估：按最終用戶

  • 概述
  • 製藥和生物技術公司
  • 合同研究所
  • 其他最終用戶

第 10 章 空間基因組學和轉錄組學市場評估：按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 拉丁美洲
  • 中東/非洲

第 11 章 競爭分析

  • 概述
  • 主要成長策略
  • 競爭標桿
  • 比賽儀表板
    • 產業領導者
    • 差異化因素
    • 先鋒隊
    • 啟動
  • 市場份額分析
    • 10X Genomics, Inc.（美國）
    • NanoString Technologies, Inc.（美國）
    • Akoya Biosciences, Inc.（美國）

第十二章 公司簡介（公司概況、財務概況、產品組合、策略發展、SWOT 分析）

  • 10X Genomics, Inc.
  • NanoString Technologies, Inc.
  • Akoya Biosciences, Inc.
  • Illumina, Inc.
  • Oxford Nanopore Technologies Plc
  • Revvity, Inc.
  • S2 Genomics, Inc.
  • Cantata Bio
  • Vizgen Inc.
  • Biospyder Technologies Inc.
  • Resolve Biosciences GmbH

（註：包含前5名企業的SWOT分析）

第十三章附錄

Product Code: MRHC - 1041080

Spatial Genomics Market by Type (Genomics, Transcriptomics) Technology (Sequencing, Imaging) Application (Oncology, Neurology) Offering (Consumables, Instrument, Software) End User (Pharmaceutical & Biotechnology, CRO)-Global Forecast to 2031

The global spatial genomics & transcriptomics market is expected to reach $3.23 billion by 2031 at a CAGR of 27.8% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the spatial genomics market is driven by the increasing applications of spatial genomics in drug discovery & development, the growing use of spatial genomics in cancer research, advancements in Next-generation Sequencing (NGS), the increasing use of spatial genomics in biomarker detection, and the rising prevalence of cancer. However, the lack of standardized approaches in genomics and concerns over the security & privacy of genomic data restrain the growth of this market.

Furthermore, the rising adoption of personalized medicines and gene therapies and increasing investments in spatial genomics are expected to generate growth opportunities for the players operating in this market. However, complexities in data analysis and slow technology adoption are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years (2020-2024). The key players operating in the global spatial genomics & transcriptomics market are NanoString Technologies, Inc. (U.S.), 10X Genomics, Inc. (U.S.), Illumina, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Akoya Biosciences, Inc. (U.S.), Revvity, Inc. (U.S.), S2 Genomics, Inc. (U.S.), Cantata Bio (U.S.), Vizgen Inc. (U.S.), Biospyder Technologies Inc. (U.S.), and Resolve Biosciences GmbH (Germany).

Among all the offerings studied in this report, the instruments segment is projected to register the highest CAGR during the forecast period. The use of instruments to profile the tumor microenvironment and the adoption of spatial transcriptomics in academics and research laboratories for drug and translational research are positively impacting the demand for instruments used in spatial genomics. Additionally, product launches by key market players support market growth. For instance, in December 2022, 10X Genomics, Inc. (U.S.) launched a Xenium Analyzer for subcellular in situ profiling.

Among all the types studied in this report, in 2024, the transcriptomics segment is expected to account for the largest share of the spatial genomics & transcriptomics market. The largest share of the segment is attributed to the increasing use of spatial transcriptomics to provide a complete roadmap of transcriptional activity within whole tissue sections required in translational research. Additionally, increasing acceptance of spatial transcriptomic technology for the identification of cellular components is driving the market growth.

Among all the technologies studied in this report, the sequencing-based segment is projected to register the highest CAGR during the forecast period. The growth of the segment is attributed to the NGS platforms offering superior sequencing capacity at substantially reduced costs, owing to which the use of NGS has increased in genomic studies to produce massive genomic sequencing data. Additionally, high throughput, low cost, individual characterization of cells, and analysis of multiple targets drive the market growth.

Among all the applications studied in this report, in 2024, the oncology segment is expected to account for the largest share of the spatial genomics & transcriptomics market. Increasing applications of spatial genomics & transcriptomics in tumor biology, such as the study of tumor heterogeneity, detecting the presence of infiltrating immune cells, and insights into tumor microenvironment, are contributing to the largest share of the segment. Additionally, the product launches by key market players are supporting the largest market share. For instance, in April 2023, Akoya Biosciences (U.S.) launched PhenoCode Discovery Panels for the advancements in cancer research.

Among all the end users studied in this report, the pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. The growth is attributed to the increasing research & development by pharmaceutical & biotechnology companies, the rising utilization of spatial genomics assays for research processes, and an increasing number of biotechnology companies. Moreover, the rising incidence of chronic diseases has accelerated the need to expedite drug development processes, further propelling the adoption of spatial genomics among pharmaceutical companies.

An in-depth analysis of the geographical scenario of the global spatial genomics & transcriptomics market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the spatial genomics & transcriptomics market. North America holds the predominant share in the region, largely due to its multitude of esteemed research institutions, universities, and organizations committed to genomics research. The region has played a pivotal role in advancing cancer genomics, driven by substantial investments in pharmaceutical research and development and the significant presence of key industry players. For instance, R&D spending by pharmaceutical companies in Canada for drug discovery has increased, driving the demand for spatial genomics. For instance, in 2020, total R&D expenditure in Canada's pharmaceutical sector was estimated at between USD 1.8 billion and USD 2.4 billion, compared to USD 1.6 billion and USD 2.2 billion in 2019

Scope of the Report:

Spatial Genomics Market Assessment, by Offering

  • Instruments
  • Consumables
  • Software & Services

Spatial Genomics Market Assessment, by Type

  • Transcriptomics
  • Genomics

Spatial Genomics Market Assessment, by Technology

  • Imaging Based
  • Sequencing Based

Spatial Genomics Market Assessment, by Application

  • Oncology
  • Neurology
  • Other Applications

Note: Other applications consist of infectious diseases and immunology.

Spatial Genomics Market Assessment, by End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Other End Users

Note: Other end users include academic institutes & research centers and agriculture companies.

Spatial Genomics Market Assessment, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
      • 4.2.1.1. Increasing Applications of Spatial Genomics in Drug Discovery & Development Driving Market Growth
      • 4.2.1.2. Lack of Standardization and Concerns Over the Privacy of Genomic Data Limiting the Adoption of Spatial Genomics Products
      • 4.2.1.3. Rising Adoption of Personalized Medicines Generating Growth Opportunities for Market Players
      • 4.2.1.4. Complexities in Data Analysis to Remain a Major Challenge Impacting Market Growth
    • 4.2.2. Factor Analysis
  • 4.3. Technology Trends
    • 4.3.1. Integration of Artificial Intelligence (AI) in Spatial Genomics
    • 4.3.2. Multiplexed Spatial Genomics
  • 4.4. Investment and Funding Scenario
  • 4.5. Pricing Analysis
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Buyers
    • 4.6.2. Bargaining Power of Suppliers
    • 4.6.3. Threat of Substitutes
    • 4.6.4. Threat of New Entrants
    • 4.6.5. Degree of Competition

5. Spatial Genomics & Transcriptomics Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Instruments
  • 5.3. Consumables
  • 5.4. Software & Services

6. Spatial Genomics & Transcriptomics Market Assessment-by Type

  • 6.1. Overview
  • 6.2. Transcriptomics
  • 6.3. Genomics

7. Spatial Genomics & Transcriptomics Market Assessment -by Technology

  • 7.1. Overview
  • 7.2. Imaging Based
  • 7.3. Sequencing Based

8. Spatial Genomics & Transcriptomics Market Assessment -by Application

  • 8.1. Overview
  • 8.2. Oncology
  • 8.3. Neurology
  • 8.4. Other Applications

9. Spatial Genomics & Transcriptomics Market Assessment -by End User

  • 9.1. Overview
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. Contract Research Organizations
  • 9.4. Other End Users

10. Spatial Genomics & Transcriptomics Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Rest of Asia-Pacific
  • 10.5. Latin America
  • 10.6. Middle East & Africa

11. Competition Analysis

  • 11.1. Overview
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share Analysis
    • 11.5.1. 10X Genomics, Inc. (U.S.)
    • 11.5.2. NanoString Technologies, Inc. (U.S.)
    • 11.5.3. Akoya Biosciences, Inc. (U.S.)

12. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, Strategic Developments, and SWOT Analysis)

  • 12.1. 10X Genomics, Inc.
  • 12.2. NanoString Technologies, Inc.
  • 12.3. Akoya Biosciences, Inc.
  • 12.4. Illumina, Inc.
  • 12.5. Oxford Nanopore Technologies Plc
  • 12.6. Revvity, Inc.
  • 12.7. S2 Genomics, Inc.
  • 12.8. Cantata Bio
  • 12.9. Vizgen Inc.
  • 12.10. Biospyder Technologies Inc.
  • 12.11 Resolve Biosciences GmbH

(Note: SWOT Analysis of Top 5 Companies is Provided)

13. Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports
  • Table 1 Estimated Number of New Cancer Cases, by Type, 2020 Vs. 2030
  • Table 2 Recent Investments and Funding in The Spatial Genomics & Transcriptomics Market
  • Table 3 Spatial Genomics & Transcriptomics Instruments: Pricing (USD/Unit)
  • Table 4 Spatial Genomics & Transcriptomics Consumables: Pricing (USD/Unit)
  • Table 5 Global Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 6 Key Companies Offering Instruments
  • Table 7 Global Spatial Genomics & Transcriptomics Market for Instruments, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Key Companies Offering Consumables
  • Table 9 Global Spatial Genomics & Transcriptomics Market for Consumables, by Country/Region, 2022-2031 (USD Million)
  • Table 10 Key Companies Offering Software
  • Table 11 Global Spatial Genomics & Transcriptomics Market for Software & Services, by Country/Region, 2022-2031 (USD Million)
  • Table 12 Global Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 13 Global Spatial Transcriptomics Market, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Spatial Genomics: Key Application Areas
  • Table 15 Global Spatial Genomics Market, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 17 Global Imaging Based Spatial Genomics & Transcriptomics Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Sequencing Based Spatial Genomics & Transcriptomics Market, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 20 Global Spatial Genomics & Transcriptomics Market for Oncology, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Global Spatial Genomics & Transcriptomics Market for Neurology, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Spatial Genomics & Transcriptomics Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 24 Global Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Global Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country/Region, 2022-2031 (USD Million)
  • Table 26 Global Spatial Genomics & Transcriptomics Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global Spatial Genomics & Transcriptomics Market, by Country/Region, 2022-2031 (USD Million)
  • Table 28 North America: Spatial Genomics & Transcriptomics Market, by Country, 2022-2031 (USD Million)
  • Table 29 North America: Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 30 North America: Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 31 North America: Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 32 North America: Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 33 North America: Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 34 U.S.: Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 35 U.S.: Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 36 U.S.: Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 37 U.S.: Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 38 U.S.: Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 39 Canada: Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 40 Canada: Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 41 Canada: Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 42 Canada: Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 43 Canada: Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 44 Europe: Spatial Genomics & Transcriptomics Market, by Country/Region, 2022-2031 (USD Million)
  • Table 45 Europe: Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 46 Europe: Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 47 Europe: Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 48 Europe: Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 49 Europe: Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 50 Germany: Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 51 Germany: Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 52 Germany: Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 53 Germany: Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 54 Germany: Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 55 France: Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 56 France: Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 57 France: Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 58 France: Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 59 France: Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 60 U.K.: Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 61 U.K.: Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 62 U.K.: Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 63 U.K.: Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 64 U.K.: Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 65 Italy: Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 66 Italy: Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 67 Italy: Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 68 Italy: Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 69 Italy: Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 70 Spain: Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 71 Spain: Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 72 Spain: Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 73 Spain: Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 74 Spain: Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 75 Rest of Europe: Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
  • Table 76 Rest of Europe: Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
  • Table 77 Rest of Europe: Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
  • Table 78 Rest of Europe: Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
  • Table 79 Rest of Europe: Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
  • Table 80 Asia-Pacific: Spatial Genomics Market, by Country/Region, 2022-2031 (USD Million)
  • Table 81 Asia-Pacific: Spatial Genomics Market, by Offering, 2022-2031 (USD Million)
  • Table 82 Asia-Pacific: Spatial Genomics Market, by Type, 2022-2031 (USD Million)
  • Table 83 Asia-Pacific: Spatial Genomics Market, by Technology, 2022-2031 (USD Million)
  • Table 84 Asia-Pacific: Spatial Genomics Market, by Application, 2022-2031 (USD Million)
  • Table 85 Asia-Pacific: Spatial Genomics Market, by End User, 2022-2031 (USD Million)
  • Table 86 China: Spatial Genomics Market, by Offering, 2022-2031 (USD Million)
  • Table 87 China: Spatial Genomics Market, by Type, 2022-2031 (USD Million)
  • Table 88 China: Spatial Genomics Market, by Technology, 2022-2031 (USD Million)
  • Table 89 China: Spatial Genomics Market, by Application, 2022-2031 (USD Million)
  • Table 90 China: Spatial Genomics Market, by End User, 2022-2031 (USD Million)
  • Table 91 Japan: Spatial Genomics Market, by Offering, 2022-2031 (USD Million)
  • Table 92 Japan: Spatial Genomics Market, by Type, 2022-2031 (USD Million)
  • Table 93 Japan: Spatial Genomics Market, by Technology, 2022-2031 (USD Million)
  • Table 94 Japan: Spatial Genomics Market, by Application, 2022-2031 (USD Million)
  • Table 95 Japan: Spatial Genomics Market, by End User, 2022-2031 (USD Million)
  • Table 96 India: Spatial Genomics Market, by Offering, 2022-2031 (USD Million)
  • Table 97 India: Spatial Genomics Market, by Type, 2022-2031 (USD Million)
  • Table 98 India: Spatial Genomics Market, by Technology, 2022-2031 (USD Million)
  • Table 99 India: Spatial Genomics Market, by Application, 2022-2031 (USD Million)
  • Table 100 India: Spatial Genomics Market, by End User, 2022-2031 (USD Million)
  • Table 101 Rest of Asia-Pacific: Spatial Genomics Market, by Offering, 2022-2031 (USD Million)
  • Table 102 Rest of Asia-Pacific: Spatial Genomics Market, by Type, 2022-2031 (USD Million)
  • Table 103 Rest of Asia-Pacific: Spatial Genomics Market, by Technology, 2022-2031 (USD Million)
  • Table 104 Rest of Asia-Pacific: Spatial Genomics Market, by Application, 2022-2031 (USD Million)
  • Table 105 Rest of Asia-Pacific: Spatial Genomics Market, by End User, 2022-2031 (USD Million)
  • Table 106 Latin America: Spatial Genomics Market, by Offering, 2022-2031 (USD Million)
  • Table 107 Latin America: Spatial Genomics Market, by Type, 2022-2031 (USD Million)
  • Table 108 Latin America: Spatial Genomics Market, by Technology, 2022-2031 (USD Million)
  • Table 109 Latin America: Spatial Genomics Market, by Application, 2022-2031 (USD Million)
  • Table 110 Latin America: Spatial Genomics Market, by End User, 2022-2031 (USD Million)
  • Table 111 Middle East & Africa: Spatial Genomics Market, by Offering, 2022-2031 (USD Million)
  • Table 112 Middle East & Africa: Spatial Genomics Market, by Type, 2022-2031 (USD Million)
  • Table 113 Middle East & Africa: Spatial Genomics Market, by Technology, 2022-2031 (USD Million)
  • Table 114 Middle East & Africa: Spatial Genomics Market, by Application, 2022-2031 (USD Million)
  • Table 115 Middle East & Africa: Spatial Genomics Market, by End User, 2022-2031 (USD Million)
  • Table 116 Recent Developments, by Company, 2020-2023

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for This Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Spatial Genomics & Transcriptomics Market, by Offering, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Spatial Genomics & Transcriptomics Market, by Type, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Spatial Genomics & Transcriptomics Market, by Technology, 2024 Vs. 2031 (USD Million)
  • Figure 10 Global Spatial Genomics & Transcriptomics Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 11 Global Spatial Genomics & Transcriptomics Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 12 Spatial Genomics & Transcriptomics Market, by Geography
  • Figure 13 Impact Analysis of Market Dynamics
  • Figure 14 Global Pharmaceutical R&D Expenditure, 2012-2026 (USD Billion)
  • Figure 15 Estimated Number of New Cancer Cases, by Region, 2020 Vs. 2030 (In Thousand)
  • Figure 16 Global Increase in The Number of Personalized Medicine Approvals, 2008-2020
  • Figure 17 Porter's Five Forces Analysis
  • Figure 18 Global Spatial Genomics & Transcriptomics Market, by Offering, 2024 Vs. 2031 (USD Million)
  • Figure 19 Global Spatial Genomics & Transcriptomics Market, by Type, 2024 Vs. 2031 (USD Million)
  • Figure 20 Global Spatial Genomics & Transcriptomics Market, by Technology, 2024 Vs. 2031 (USD Million)
  • Figure 21 Imaging Based Methods: Workflow
  • Figure 22 Sequencing Based Methods: Workflow
  • Figure 23 Global Spatial Genomics & Transcriptomics Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 24 Global Spatial Genomics & Transcriptomics Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 25 Global Pharmaceutical R&D Spending, 2012-2026 (USD Billion)
  • Figure 26 Global Spatial Genomics & Transcriptomics Market, by Region, 2024 Vs. 2031 (USD Million)
  • Figure 27 North America: Spatial Genomics & Transcriptomics Market Snapshot
  • Figure 28 U.S.: Pharmaceutical R&D Expenditures, 2014-2021 (USD Billion)
  • Figure 29 Europe: Pharmaceutical R&D Expenditures, 2000-2021 (USD Million)
  • Figure 30 Europe: Spatial Genomics & Transcriptomics Market Snapshot
  • Figure 31 Roe: Countries Pharmaceutical R&D Expenditures, 2021 (USD Million)
  • Figure 32 Asia-Pacific: Spatial Genomics Market Snapshot
  • Figure 33 Key Growth Strategies Adopted by Leading Players, 2020-2023
  • Figure 34 Spatial Genomics & Transcriptomics Market: Competitive Benchmarking (Based on Offering)
  • Figure 35 Spatial Genomics & Transcriptomics Market: Competitive Benchmarking (Based on Geography)
  • Figure 36 Competitive Dashboard: Spatial Genomics & Transcriptomics Market
  • Figure 37 Global Spatial Genomics & Transcriptomics Market Share Analysis, by Key Players (2023)
  • Figure 38 10x Genomics, Inc.: Financial Overview (2022)
  • Figure 39 NanoString Technologies, Inc.: Financial Overview (2022)
  • Figure 40 Akoya Biosciences, Inc.: Financial Overview (2022)
  • Figure 41 Illumina, Inc.: Financial Overview (2022)
  • Figure 42 Oxford Nanopore Technologies Plc.: Financial Overview (2022)
  • Figure 43 PerkinElmer, Inc: Financial Overview (2022)